Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FL4G8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,199
Award facts
- Contract value 100% obligated
- $16,198.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,198.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count units), with an ultimate completion date of October 30, 2025. This non-set-aside competitive award represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order falls within AmerisourceBergen's extensive portfolio of pharmaceutical supplies provided to the Defense Health Agency and other federal healthcare systems. Gemtesa (mirabegron) is a prescription medication used in the treatment of overactive bladder, reflecting the company's role in supplying specialty medications across multiple therapeutic domains to support military and veteran healthcare programs. The competitive delivery order mechanism demonstrates the vendor's capability to meet federal procurement requirements while maintaining firm fixed pricing, consistent with the company's demonstrated track record of fulfilling diverse medical supply needs for the Department of Defense.
Quick answers
Who was awarded contract SPE2DB26FL4G8?
SPE2DB26FL4G8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FL4G8 worth?
The government has obligated $16,199 on SPE2DB26FL4G8.
Is contract SPE2DB26FL4G8 an order under another contract?
Yes. SPE2DB26FL4G8 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL4G8 competed?
The extent of competition for SPE2DB26FL4G8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award